|
SKA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.88258347483861E-15 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.94360000000438E-05 |
| Normal-vs-Stage2 |
2.711800E-02 |
| Normal-vs-Stage3 |
3.94540000000498E-05 |
| Normal-vs-Stage4 |
2.628400E-02 |
| Stage1-vs-Stage2 |
6.640000E-01 |
| Stage1-vs-Stage3 |
2.698000E-03 |
| Stage1-vs-Stage4 |
1.023550E-01 |
| Stage2-vs-Stage3 |
6.923900E-02 |
| Stage2-vs-Stage4 |
1.617000E-01 |
| Stage3-vs-Stage4 |
6.472600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.50899975742891E-10 |
| Normal-vs-AfricanAmerican |
1.82595999999036E-05 |
| Normal-vs-Asian |
8.440500E-02 |
| Caucasian-vs-AfricanAmerican |
6.078800E-01 |
| Caucasian-vs-Asian |
2.057800E-01 |
| AfricanAmerican-vs-Asian |
2.684000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.39777078800307E-13 |
| Normal-vs-Female |
4.28470000000125E-05 |
| Male-vs-Female |
5.323800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.630000E-04 |
| Normal-vs-Extreme_Weight |
2.72810000034873E-07 |
| Normal-vs-Obese |
1.19880000004624E-06 |
| Normal-vs-Extreme_Obese |
2.833600E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.556300E-02 |
| Normal_Weight-vs-Obese |
3.601200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.403500E-03 |
| Extreme_Weight-vs-Obese |
1.085170E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.006100E-02 |
| Obese-vs-Extreme_Obese |
1.340640E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.295330E-03 |
| Normal-vs-Age(41-60Yrs) |
3.59600016430761E-10 |
| Normal-vs-Age(61-80Yrs) |
2.45369999999356E-05 |
| Normal-vs-Age(81-100Yrs) |
1.318070E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.420400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.012400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.207900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.309000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.740580E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.334800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.7492673975994E-12 |
| Normal-VS-Type2 PRCC |
4.78400000003543E-06 |
| Normal-VS-KIRP CIMP |
8.617600E-04 |
| Normal-VS-Unclassified PRCC |
1.397970E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.892300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.280700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.871700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.63830000005283E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
7.945000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.539100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.00369999999928E-05 |
| Normal-vs-N1 |
1.95842999999307E-05 |
| Normal-vs-N2 |
6.964000E-02 |
| N0-vs-N1 |
1.900520E-03 |
| N0-vs-N2 |
2.429400E-01 |
| N1-vs-N2 |
4.309200E-01 |
|
|
